China Pharma Holdings (CPHI) Depreciation & Amortization (CF) (2010 - 2026)

China Pharma Holdings (CPHI) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Depreciation & Amortization (CF) rose 243.4% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $2.9 million (up 63.54% YoY), and the FY2025 full-year result was $1.5 million, down 42.57% from the prior year.
• Depreciation & Amortization (CF) grew to $1.1 million in Q2 2026 per CPHI's latest filing, from $980570.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q2 2026 and bottomed at $320863.0 in Q2 2025.
• Historically, Depreciation & Amortization (CF) has averaged $647684.0 across 5 years, with a median of $683154.0 in 2022.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) tumbled 56.6% in 2025, then soared 243.4% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $639425.0 in 2022, then climbed by 8.82% to $695835.0 in 2023, then tumbled by 35.61% to $448073.0 in 2024, then increased by 11.01% to $497425.0 in 2025, then jumped by 121.51% to $1.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.1 million, $980570.0, and $497425.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.